FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Resources - All Kinds, Realm US

21,577 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

By Authority

 

Start Prev Rows 12400 - 12600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthUsage #
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.10.jsonCodes for Healthcare Personnel Influenza Vaccination (HP FLU) Summary Dataactive2019-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.11.jsonCodes for Hemovigilance (HV) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.12.jsonCodes for Intensive Care Unit (ICU) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.13.jsonCodes for Neonatal Intensive Care Unit (NICU) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.15.jsonCodes for Prevention Process and Outcome Measures (POM) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.16.jsonCodes for Specialty Care Area (SCA) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.17.jsonCodes for Vascular Access Type (Dialysis) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.18.jsonNHSNReportNoEventsICUactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.19.jsonNHSNReportNoEventsNICUactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.20.jsonNHSNReportNoEventsSCAactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.21.jsonNHSNReportNoEventsMDROactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.22.jsonNHSNReportNoEventsDialysisactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.24.jsonNHSNVascularSpecimenCollectionSiteactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.29.jsonNHSNSSIDetectionMethodactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.3.jsonNHSNLastLocationEncounterTypeCodeactive2020-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.30.jsonNHSNLOS/MENDischargeDispositionactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.31.jsonNHSNSSIDetectionMethodTypeactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.32.jsonCodes for Outpatient Procedure Component Same Day Outcome Measures Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.33.jsonNHSNReportNoEventsOPCSameDayOutcomeMeasuresactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.34.jsonNHSNOPCProcedureCategoryCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.35.jsonNHSNReportNoEventsARactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.4.jsonNHSNDrugSusceptibilityTestMethodactive2020-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.40.jsonNHSN COVID19 Case Classificationactive2021-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.5.jsonNHSN Pathogen Reduced Apheresis Platelet Usageactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.50.jsonNHSNGenotypicTestInterpretationactive2024-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.6.jsonHealthcarePersonnelTypeactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.7.jsonNHSNInfluenzaVaccinationSettingactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.8.jsonCodes for Antimicrobial Resistance Option (ARO) Summary Dataactive2020-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.9.9.jsonCodes for Antimicrobial Usage, Pharmacy (AUP) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.12.1.jsonPersonal And Legal Relationship Role Typeactive2024-06hl713
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.9.21.jsonAgePQ_UCUMactive2024-06hl73
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.9.32.jsonDIRDocumentTypeCodesactive2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.9.47.jsonADL Result Typeactive2024-06hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.9.49.jsonResidence and Accommodation Typeactive2024-06hl74
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.9.50.jsonSensory Status Problem Typeactive2024-06hl73
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.9.51.jsonHealthcare Agent Qualifieractive2024-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.9.52.jsonEncounter SCTactive2024-10hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.9.56.jsonReferral Typesactive2024-06hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.9.62.jsonRelated Document (append/replace)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.9.66.jsonPatient Referral Act moodCodeactive2024-06hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.9.68.jsonNote Typesactive2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.11.20.9.69.4.jsonAdvance Healthcare Directive Categories LOINCactive2025-04hl75
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.1.jsonNHSNEncounterTypeCodeactive2019-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.10.jsonNHSNASAClassCodeactive2019-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.11.jsonNHSNSpinalFusionLevelCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.12.jsonNHSNOccasionOfDetectionCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.13.jsonNHSNDrugSusceptibilityFindingCodeactive2020-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.15.jsonNHSNDrugSusceptibilityTestsCodeactive2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.16.jsonNHSNPathogenCodeactive2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.17.jsonNHSNProcedureCategoryCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.19.jsonNHSNHealthcareServiceLocationCodeactive2019-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.2.jsonNHSNSpinalFusionApproachCodeactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.20.jsonNHSNInfectionTypeCodeactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.3.jsonNHSNHipReplacementCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.4.jsonNHSNKneeReplacementCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.6.jsonNHSNInfectionRiskFactorsCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.7.jsonNHSNBloodStreamInfectionEvidenceTypeCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.13.9.jsonNHSNWoundClassCodeactive2020-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.17.4077.2.1017.jsonClosed Head and Facial Traumaactive2020-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.17.4077.2.1018.jsonClosed Head and Facial Traumaactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.134.jsonOral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatmentactive2022-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.136.jsonPerforation of Uterusactive2024-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.137.jsonUterine Windowactive2021-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.138.jsonUterine Ruptureactive2024-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.200.jsonAnticoagulant Therapyactive2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.201.jsonAntithrombotic Therapy Anticoagulantactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.202.jsonAtrial Fibrillation or Flutteractive2024-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.203.jsonAtrial Ablationactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.204.jsonCarotid Interventionactive2024-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.205.jsonDirect Thrombin Inhibitoractive2024-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.207.jsonDischarged to Health Care Facility for Hospice Careactive2021-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.209.jsonDischarged to Home for Hospice Careactive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.211.jsonInjectable Factor Xa Inhibitor for VTE Prophylaxisactive2021-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.212.jsonHemorrhagic Strokeactive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.213.jsonINRactive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.214.jsonIntermittent pneumatic compression devicesactive2023-01hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.215.jsonLDLcactive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.218.jsonUnfractionated Heparinactive2021-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.219.jsonLow Molecular Weight Heparin for VTE Prophylaxisactive2023-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.222.jsonIntravenous routeactive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.223.jsonSubcutaneous routeactive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.226.jsonThrombolytic tPA Therapyactive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.230.jsonVenous foot pumpsactive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.232.jsonWarfarinactive2021-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.234.jsonHemorrhagic Strokeactive2021-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.235.jsonHemorrhagic Strokeactive2021-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.238.jsonCarotid Interventionactive2025-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.239.jsonCarotid Interventionactive2019-03hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.242.jsonAtrial Ablationactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.243.jsonAtrial Ablationactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.244.jsonAtrial Fibrillation or Flutteractive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.245.jsonAtrial Fibrillation or Flutteractive2021-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.246.jsonAtrial Fibrillation or Flutteractive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.247.jsonIschemic Strokeactive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.25.jsonSingle Live Birthactive2021-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.251.jsonIschemic Stroke Embolismactive2021-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.252.jsonIschemic Stroke Embolismactive2021-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.255.jsonGeneral Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.256.jsonGraduated compression stockingsactive2024-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.257.jsonGynecological Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.258.jsonHip Fracture Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.259.jsonHip Replacement Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.26.jsonSingle Live Born Newborn Born in Hospitalactive2021-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.260.jsonIntracranial Neurosurgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.261.jsonKnee Replacement Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.263.jsonObstetrical or Pregnancy Related Conditionsactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.264.jsonObstetrics VTEactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.27.jsonDietary Intake Other than Human Milkactive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.270.jsonAcute or Persistent Asthmaactive2022-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.271.jsonAcute or Persistent Asthmaactive2022-01hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.272.jsonUrological Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.279.jsonVenous Thromboembolismactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.281.jsonLaboractive2021-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.282.jsonCesarean Birthactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.286.jsonConditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestationactive2021-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.288.jsonMedical Induction of Laboractive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.292.jsonEmergency Department Visitactive2021-06hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.294.jsonDecision to Admit to Hospital Inpatientactive2021-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.295.jsonDecision to Admit to Hospital Inpatientactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.296.jsonPsychiatric/Mental Health Diagnosisactive2024-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.298.jsonPsychiatric/Mental Health Diagnosisactive2024-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.299.jsonPsychiatric/Mental Health Diagnosisactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.30.jsonHuman Milkactive2025-05hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.308.jsonLeft Against Medical Adviceactive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.309.jsonPatient Expiredactive2021-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.310.jsonGynecological Surgeryactive2024-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.313.jsonGynecological Surgeryactive2023-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.315.jsonKnee Replacement Surgeryactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.317.jsonKnee Replacement Surgeryactive2023-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.319.jsonHip Replacement Surgeryactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.321.jsonHip Replacement Surgeryactive2024-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.323.jsonHip Fracture Surgeryactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.325.jsonHip Fracture Surgeryactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.328.jsonVenous Thromboembolismactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.33.jsonGalactosemiaactive2024-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.330.jsonVenous Thromboembolismactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.331.jsonUrological Surgeryactive2024-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.333.jsonUrological Surgeryactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.335.jsonObstetrical or Pregnancy Related Conditionsactive2024-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.337.jsonObstetrical or Pregnancy Related Conditionsactive2025-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.338.jsonObstetrics VTEactive2021-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.340.jsonObstetrics VTEactive2024-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.344.jsonIntracranial Neurosurgeryactive2021-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.346.jsonIntracranial Neurosurgeryactive2025-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.348.jsonGeneral or Neuraxial Anesthesiaactive2021-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.35.jsonGalactosemiaactive2021-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.361.jsonGeneral Surgeryactive2021-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.365.jsonGeneral Surgeryactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.367.jsonCesarean Birthactive2021-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.369.jsonCesarean Birthactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.37.jsonParenteral Nutritionactive2021-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.38.jsonParenteral Nutritionactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.384.jsonMedical Induction of Laboractive2024-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.393.jsonConditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestationactive2024-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.395.jsonConditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestationactive2025-05hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.400.jsonLow Riskactive2024-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.401.jsonDelivery Proceduresactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.418.jsonClassical Cesarean Birthactive2024-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.419.jsonClassical Cesarean Birthactive2021-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.421.jsonClassical Cesarean Birthactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.422.jsonMyomectomyactive2024-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.423.jsonStatin Allergenactive2021-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.424.jsonNonelective Inpatient Encounteractive2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.473.jsonMedical Reason For Not Providing Treatmentactive2022-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.75.jsonNeonatal Intensive Care Unitactive2021-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.76.jsonSingle Live born Newbornactive2021-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.78.jsonGalactosemiaactive2021-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.79.jsonParenteral Nutritionactive2021-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.87.jsonDischarge To Acute Care Facilityactive2021-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.117.1.7.1.93.jsonPatient Refusalactive2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1434.1047.jsonSkin Melanoma pT1active2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.100.jsonInjectable Fluorouracilactive2020-09hl73
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.101.jsonTrastuzumab and Biosimilarsactive2023-07hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.102.jsonBreast Canceractive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.103.jsonHER2 Presence in Tissueactive2020-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.104.jsonDepression Screening for Adultactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.105.jsonLong Acting Opioidsactive2024-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.106.jsonHigh Fiber Supplement or Diet Educationactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.107.jsonStandardized Assessment Tools for Dyspneaactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.108.jsonNausea or Vomiting Assessmentactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.109.jsonPancreatic Canceractive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.110.jsonPancreatic Canceractive2023-07hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.111.jsonAudio Visual Telehealth Encounteractive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.112.jsonTelephone Encounteractive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.113.jsonTelehealth Emergency Department or Initial Inpatientactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.114.jsonKarnofsky Performance Statusactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.115.jsonReferral to Hospice Careactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.116.jsonReferral to Palliative Careactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.117.jsonAssessment Scale for Dyspneaactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.118.jsonNausea or Vomiting Assessmentactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.119.jsonEnrollment in Hospice Careactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.120.jsonPalliative Careactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.121.jsonAdvance Directive Including Durable Power of Attorney or Instructionalactive2020-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.122.jsonCarmustine Injectableactive2022-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.123.jsonDacarbazine Injectableactive2021-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.124.jsonStreptozocin Injectableactive2021-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.126.jsonAlemtuzumab Injectableactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.127.jsonAzacitidine Injectableactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.128.jsonBendamustine Injectableactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.3.1444.3.129.jsonBusulfan Injectableactive2021-03hl7